Making data map-worthy—enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study
| dc.contributor.author | Kagoro, Frank M. | |
| dc.contributor.author | Allen, Elizabeth | |
| dc.contributor.author | Mabuza, Aaron | |
| dc.contributor.author | Workman, Lesley | |
| dc.contributor.author | Magagula, Ray | |
| dc.contributor.author | Kok, Gerdalize | |
| dc.contributor.author | Davies, Craig | |
| dc.contributor.author | Malatje, Gillian | |
| dc.contributor.author | Guérin, Philippe J | |
| dc.contributor.author | Dhorda, Mehul | |
| dc.contributor.author | Maude, Richard J | |
| dc.contributor.author | Raman, Jaishree | |
| dc.contributor.author | Barnes, Karen I | |
| dc.date.accessioned | 2022-07-08T06:45:32Z | |
| dc.date.available | 2022-07-08T06:45:32Z | |
| dc.date.issued | 2022-06-29 | |
| dc.date.updated | 2022-07-03T03:11:15Z | |
| dc.description.abstract | Background Independent emergence and spread of artemisinin-resistant Plasmodium falciparum malaria have recently been confirmed in Africa, with molecular markers associated with artemisinin resistance increasingly detected. Surveillance to promptly detect and effectively respond to anti-malarial resistance is generally suboptimal in Africa, especially in low transmission settings where therapeutic efficacy studies are often not feasible due to recruitment challenges. However, these communities may be at higher risk of anti-malarial resistance. Methods From March 2018 to February 2020, a sequential mixed-methods study was conducted to evaluate the feasibility of the near-real-time linkage of individual patient anti-malarial resistance profiles with their case notifications and treatment response reports, and map these to fine scales in Nkomazi sub-district, Mpumalanga, a pre-elimination area in South Africa. Results Plasmodium falciparum molecular marker resistance profiles were linked to 55.1% (2636/4787) of notified malaria cases, 85% (2240/2636) of which were mapped to healthcare facility, ward and locality levels. Over time, linkage of individual malaria case demographic and molecular data increased to 75.1%. No artemisinin resistant validated/associated Kelch-13 mutations were detected in the 2385 PCR positive samples. Almost all 2812 samples assessed for lumefantrine susceptibility carried the wildtype mdr86ASN and crt76LYS alleles, potentially associated with decreased lumefantrine susceptibility. Conclusion Routine near-real-time mapping of molecular markers associated with anti-malarial drug resistance on a fine spatial scale provides a rapid and efficient early warning system for emerging resistance. The lessons learnt here could inform scale-up to provincial, national and regional malaria elimination programmes, and may be relevant for other antimicrobial resistance surveillance. | en_US |
| dc.identifier.apacitation | Kagoro, Frank M., Allen, E., Mabuza, A., Workman, L., Magagula, R., Kok, G., ... Barnes, K. I. (2022). Making data map-worthy—enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study. <i>Malaria Journal</i>, 21(1), 207. http://hdl.handle.net/11427/36629 | en_ZA |
| dc.identifier.chicagocitation | Kagoro, Frank M., Elizabeth Allen, Aaron Mabuza, Lesley Workman, Ray Magagula, Gerdalize Kok, Craig Davies, et al "Making data map-worthy—enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study." <i>Malaria Journal</i> 21, 1. (2022): 207. http://hdl.handle.net/11427/36629 | en_ZA |
| dc.identifier.citation | Kagoro, Frank M., Allen, E., Mabuza, A., Workman, L., Magagula, R., Kok, G., Davies, C. & Malatje, G. et al. 2022. Making data map-worthy—enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study. <i>Malaria Journal.</i> 21(1):207. http://hdl.handle.net/11427/36629 | en_ZA |
| dc.identifier.ris | TY - Journal Article AU - Kagoro, Frank M. AU - Allen, Elizabeth AU - Mabuza, Aaron AU - Workman, Lesley AU - Magagula, Ray AU - Kok, Gerdalize AU - Davies, Craig AU - Malatje, Gillian AU - Guérin, Philippe J AU - Dhorda, Mehul AU - Maude, Richard J AU - Raman, Jaishree AU - Barnes, Karen I AB - Background Independent emergence and spread of artemisinin-resistant Plasmodium falciparum malaria have recently been confirmed in Africa, with molecular markers associated with artemisinin resistance increasingly detected. Surveillance to promptly detect and effectively respond to anti-malarial resistance is generally suboptimal in Africa, especially in low transmission settings where therapeutic efficacy studies are often not feasible due to recruitment challenges. However, these communities may be at higher risk of anti-malarial resistance. Methods From March 2018 to February 2020, a sequential mixed-methods study was conducted to evaluate the feasibility of the near-real-time linkage of individual patient anti-malarial resistance profiles with their case notifications and treatment response reports, and map these to fine scales in Nkomazi sub-district, Mpumalanga, a pre-elimination area in South Africa. Results Plasmodium falciparum molecular marker resistance profiles were linked to 55.1% (2636/4787) of notified malaria cases, 85% (2240/2636) of which were mapped to healthcare facility, ward and locality levels. Over time, linkage of individual malaria case demographic and molecular data increased to 75.1%. No artemisinin resistant validated/associated Kelch-13 mutations were detected in the 2385 PCR positive samples. Almost all 2812 samples assessed for lumefantrine susceptibility carried the wildtype mdr86ASN and crt76LYS alleles, potentially associated with decreased lumefantrine susceptibility. Conclusion Routine near-real-time mapping of molecular markers associated with anti-malarial drug resistance on a fine spatial scale provides a rapid and efficient early warning system for emerging resistance. The lessons learnt here could inform scale-up to provincial, national and regional malaria elimination programmes, and may be relevant for other antimicrobial resistance surveillance. DA - 2022-06-29 DB - OpenUCT DP - University of Cape Town IS - 1 J1 - Malaria Journal KW - Artemisinin resistance KW - Kelch 13, k13 KW - Lumefantrine KW - Plasmodium falciparum KW - Africa KW - Spatiotemporal model KW - Malaria LK - https://open.uct.ac.za PY - 2022 T1 - Making data map-worthy—enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study TI - Making data map-worthy—enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study UR - http://hdl.handle.net/11427/36629 ER - | en_ZA |
| dc.identifier.uri | https://doi.org/10.1186/s12936-022-04224-4 | |
| dc.identifier.uri | http://hdl.handle.net/11427/36629 | |
| dc.identifier.vancouvercitation | Kagoro Frank M, Allen E, Mabuza A, Workman L, Magagula R, Kok G, et al. Making data map-worthy—enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study. Malaria Journal. 2022;21(1):207. http://hdl.handle.net/11427/36629. | en_ZA |
| dc.language.iso | en | en_US |
| dc.language.rfc3066 | en | |
| dc.publisher.department | Division of Clinical Pharmacology | en_US |
| dc.publisher.faculty | Faculty of Health Sciences | en_US |
| dc.rights.holder | The Author(s) | |
| dc.source | Malaria Journal | en_US |
| dc.source.journalissue | 1 | en_US |
| dc.source.journalvolume | 21 | en_US |
| dc.source.pagination | 207 | en_US |
| dc.source.uri | https://malariajournal.biomedcentral.com/ | |
| dc.subject | Artemisinin resistance | en_US |
| dc.subject | Kelch 13, k13 | en_US |
| dc.subject | Lumefantrine | en_US |
| dc.subject | Plasmodium falciparum | en_US |
| dc.subject | Africa | en_US |
| dc.subject | Spatiotemporal model | en_US |
| dc.subject | Malaria | en_US |
| dc.title | Making data map-worthy—enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study | en_US |
| dc.type | Journal Article | en_US |